# Sakar Healthcare Limited (SAKAR)

> SAKAR closed at ₹939.00 on 30 Oct 2026, trailing P/E 48.7, market cap ₹2,089 cr, latest results for the quarter ended 30 Sept 2026. Revenue, profit, ROE, debt, own P/E range and sector-peer comparison from the SEBI filing.

Sakar Healthcare Limited (NSE: SAKAR) closed at ₹939.00 on 30 Oct 2026, +167.1% over one year, against a 52-week range of ₹350.10 – ₹1,229.85.

In the quarter ended 30 Sept 2026 (consolidated, filed 23 Oct 2026) it reported revenue of ₹87 cr and net profit of ₹11 cr, a 12.9% net margin; revenue grew 51.9% and profit grew 199.0% year on year.

On four consecutive filed quarters its trailing P/E is 48.7; since 16 May 2025 its own P/E has ranged from 38.2 to 73.4 (median 48.4), and today's reading is higher than 52% of those 360 trading days.

From the balance sheet dated 30 Sept 2026: return on equity 13.1%, ROCE 18.2%, debt-to-equity 0.13, Piotroski F-score 8 of 9.

Against 66 Healthcare peers on NSE: Net margin higher than 52% of 64 sector peers; PBT margin higher than 53% of 64 sector peers; ROE higher than 45% of 64 sector peers.

## Key figures

| Figure | Value |
|---|---|
| Last close | ₹939.00 (30 Oct 2026) |
| Change 1 month / 6 months / 1 year | -16.8% / +49.3% / +167.1% |
| 52-week low – high | ₹350.10 – ₹1,229.85 |
| Market capitalisation | ₹2,089 cr |
| Trailing P/E | 48.7 |
| Price / book | 6.04 |
| EV / EBITDA | 23.0 |
| Earnings yield | 2.1% |
| TTM EPS | ₹19.27 |
| TTM net profit | ₹43 cr |
| Quarter revenue | ₹87 cr |
| Quarter net profit | ₹11 cr |
| Net margin | 12.9% |
| Revenue growth (YoY) | +51.9% |
| Profit growth (YoY) | +199.0% |
| Return on equity | 13.1% |
| ROCE | 18.2% |
| Debt / equity | 0.13 |
| Current ratio | 1.34 |
| Free cash flow | ₹1 cr |
| Piotroski F-score | 8 / 9 |
| Average daily turnover (50 days) | ₹11.1 cr |

## Questions

### What is the P/E ratio of Sakar Healthcare Limited?

Sakar Healthcare Limited's trailing P/E is 48.7, using the close of 30 Oct 2026 and earnings over the four filed quarters to 30 Sept 2026. Since 16 May 2025 its P/E has ranged 38.2–73.4.

### What were Sakar Healthcare Limited's latest quarterly results?

For the quarter ended 30 Sept 2026, Sakar Healthcare Limited reported revenue of ₹87 cr and net profit of ₹11 cr (consolidated), filed with the exchange on 23 Oct 2026.

### What is Sakar Healthcare Limited's ROE?

Return on equity is 13.1% based on the balance sheet dated 30 Sept 2026.

### Does Sakar Healthcare Limited have debt?

Debt-to-equity is 0.13 on the balance sheet dated 30 Sept 2026.

### What is SAKAR's 52-week high and low?

Over the last 52 weeks to 30 Oct 2026, SAKAR traded between ₹350.10 and ₹1,229.85.

Sector: [Healthcare](https://trinetra.trade/sectors/healthcare) · Page: https://trinetra.trade/fundamentals/SAKAR

_TRINETRA is a research and education tool. Nothing on this site is investment advice or a recommendation to buy or sell any security. Markets carry risk; do your own research and consult a SEBI-registered adviser before investing._